• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM; STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING Back to Search Results
Model Number 24653
Device Problem Fracture (1260)
Patient Problems Pain (1994); Obstruction/Occlusion (2422)
Event Date 05/31/2021
Event Type  Injury  
Manufacturer Narrative
Initial reporter city: (b)(6).
 
Event Description
It was reported that the stent fractured and occluded.The patient experienced pain due to this.A 6x120 cm eluvia drug-eluting vascular stent system was selected for the patient procedure on (b)(6) 2020.The patient had peripheral artery disease.The lesion was moderately tortuous, 100% stenosed, and severely calcified.The treatment site was a chronic total occlusion at the left superficial femoral artery and popliteal artery.The stent was placed from "p1 to p2." on (b)(6) 2021, the patient presented to the physician due to pain in the lower limb.When examined, the distal side (p2 part) of the eluvia was separated.Follow-up contrast was performed and found an occlusion within the eluvia.Collateral circulation was noted, so below the knee circulation has persisted due to the blood flow from the collateral circulation.A high fracture tolerance of the eluvia stent was found, and it was stated that the location where the device was placed (p2) was not good.No additional interventions or adverse effects were reported.A bypass surgery will be scheduled sometime in the future; it has not yet been scheduled.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELUVIA DRUG-ELUTING VASCULAR STENT SYSTEM
Type of Device
STENT, SUPERFICIAL FEMORAL ARTERY, DRUG-ELUTING
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC CORPORATION
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key12046012
MDR Text Key257719185
Report Number2134265-2021-07883
Device Sequence Number1
Product Code NIU
Combination Product (y/n)Y
Reporter Country CodeJA
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial
Report Date 06/22/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date11/14/2021
Device Model Number24653
Device Catalogue Number24653
Device Lot Number0024941648
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 05/31/2021
Initial Date FDA Received06/22/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured11/15/2019
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Other;
Patient Age69 YR
-
-